Pharmaceutical Drug Regulatory Affairs Journal (PDRAJ)
Pharmaceutical Drug Regulatory Affairs Journal is an internationally peer-reviewed journal that deals with broad range of new profession which developed from the desire of governments to protect public health by controlling the safety and efficacy of products.
Clinical Research and Regulatory Affairs: Vol 33, No 2-4
This journal. Aims and scope; Journal information; Advertising information; ... Changes to protocol in the regulation of adverse drug reactions – historical and current European view ... Regulatory Perspectives . article commentary. Increasing the odds of effective drug development: Elevating regulatory affairs professionals to strategic ......
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
International Journal of Drug Regulatory Affairs; 2014, 2(1), 1- 11 Abstract: Developing a new drug requires great amount of research work in chemistry, manufacturing, controls, preclinical science and clinical trials.
Drug Information Association
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd. "DIA quickly became a valuable place not only for education, but for networking and leadership growth as well.
Locum Int - Journal of Drug Development - Editorial
The International Journal of Drug Development publishes articles and reviews on all aspects of Pharmaceutical Drug Development from pre-formulation to aspects of regulatory strategy. Emphasis is placed on US and EC exposure to the Drug Development Industry with special reference to the on-time development of EU Dossiers, NDA & ANDA submissions....